E-2 Visa Business Plan for a Medical Practice

A well-capitalized medical practice satisfies the core E-2 investment thresholds without difficulty. Buildout of a clinical space (exam rooms, waiting area, nurse station, ADA-compliant restrooms) commonly ranges from $150,000 to $500,000. Medical equipment — diagnostic machines, exam tables, EHR systems, sterilization units — adds a further $50,000 to $300,000 depending on specialty. Working capital to cover payroll, malpractice insurance premiums, and operating costs through the first billing-cycle lag is a further documented expense. Total pre-revenue investment for even a modest two-physician primary care office routinely falls between $250,000 and $800,000, a range that comfortably supports the proportionality test under 9 FAM 402.9-7(B).

The failure points cluster around two issues. First, marginality: if the practice will generate enough revenue to support only the investor-physician's own compensation, the officer can find that the enterprise exists mainly to provide a living for the investor — the classic marginal-enterprise disqualification under 9 FAM 402.9-9(A). Second, the develop-and-direct requirement: a physician who intends to see patients full-time while a practice manager handles all business decisions may be unable to demonstrate that the investor is 'directing and developing' the enterprise as required by 8 CFR 214.2(e)(2)(i). Both concerns are addressable; neither is fatal if the plan is structured with them in mind.

Before drafting any section of the business plan, the investor and their attorney must verify how the relevant state regulates physician-owned practices. Most states permit a physician to own a medical practice directly — as a sole proprietor, professional corporation (PC), or professional limited liability company (PLLC) — and an E-2 investor who is also a licensed physician can structure the entity accordingly. A handful of states (California, Texas, New York, and others) enforce corporate-practice-of-medicine (CPOM) doctrine, which prohibits non-physician entities from owning or controlling a medical practice. In those states, the structure typically involves a management services organization (MSO): the E-2 investor owns the MSO, which provides administrative, billing, facilities, and personnel services to the physician-owned PC or PLLC under a management services agreement (MSA).

The business plan must explain the entity structure clearly. An officer who sees 'E-2 investor owns the medical practice' in a CPOM state without any explanation of the MSO-PC arrangement may raise a legal concern that the entity structure is invalid, which undermines the bona fide enterprise requirement under 9 FAM 402.9-8. The plan should identify the state, confirm whether CPOM applies, describe the entity or entities formed, and explain how the investor controls the operation consistent with applicable law. Attach the organizational documents (articles of incorporation or organization, operating agreement or bylaws, MSA if applicable) in the exhibits.

The develop-and-direct requirement under 8 CFR 214.2(e)(2)(i) demands that the treaty investor 'develop and direct the enterprise.' For a medical practice, this means the investor must function as the principal executive of the business — setting clinical and operational strategy, hiring and supervising staff, managing vendor and payer relationships, and making capital decisions — not merely as a treating physician who has also written a check.

This distinction matters more in medical practice applications than in most other industries because the natural instinct of a physician-investor is to identify as a clinician. The business plan must show that the investor's primary function is executive management. A useful approach is to divide the investor's time explicitly: the management section of the plan should describe the hours per week spent on practice administration (credentialing, payer contracting, hiring, financial oversight) versus direct patient care, and argue that the administrative role constitutes developing and directing the enterprise. Many successful applications present the investor as a managing physician whose clinical work is one element of the role rather than the entire job, and who will delegate clinical expansion to hired associates as the practice grows.

If the investor is not a licensed physician and is opening a practice staffed entirely by employed physicians, the executive-operator argument is straightforward: the investor is clearly not practicing medicine and instead manages a healthcare business. The plan should still describe the staffing model, clinical director structure, and how the investor will exercise day-to-day control through performance metrics, budget authority, and strategic direction.

The investment must be 'at risk in the commercial sense' under 9 FAM 402.9-7(A), meaning the funds must be committed to the enterprise — not sitting in a personal bank account earmarked for future use. For a medical practice that has not yet opened, the documentary record should include signed commercial lease or letter of intent, contractor bids or signed construction contracts for buildout, equipment purchase orders or financing agreements, and vendor deposits. Pre-opening expenses that have been paid — such as architectural fees, permit applications, licensing fees, and security deposits — are qualifying investment expenditures and should be itemized.

The business plan's investment section should present a startup costs table organized by category: leasehold improvements, medical and office equipment, IT infrastructure and EHR system, initial supplies and medications, professional fees (legal, accounting, licensing), insurance premiums (malpractice, general liability), working capital reserve, and any franchise or licensing fees if the practice operates under a franchise model. Total each category and reconcile the total to the source-of-funds documentation in the exhibits. Officers will cross-check the investment total in the plan against the bank records and wire transfer confirmations.

The non-marginality requirement under 9 FAM 402.9-9(A) demands that the enterprise have 'present or future capacity to make a significant economic contribution.' For medical practices, the staffing plan is the primary vehicle for demonstrating that contribution. A plan that projects one physician (the investor) supported by one medical assistant generates very little employment beyond the investor and will likely be found marginal. A plan that projects a front-desk coordinator, a medical assistant or clinical nurse, a billing specialist, and a part-time office manager — with a roadmap to hiring additional clinical staff in years two and three — presents a meaningfully different picture.

The staffing plan must include projected hire dates, job titles, full-time-equivalent counts, and annual compensation. It should be tied to the financial projections: if the plan projects $1.2 million in revenue in year two, the corresponding staff expenses (salaries, payroll taxes, benefits) should appear as a line item in the income statement. An officer who sees a revenue projection that implies a heavy patient volume but a staffing projection showing only the investor will question the internal consistency of the plan.

Non-U.S. citizen employees may be employed at the practice, but they must have independent work authorization. The business plan should clarify that any non-citizen staff will be hired with appropriate documentation; this avoids a common adjudicatory concern that the investor intends to use the E-2 enterprise as a vehicle to employ family members or nationals of the treaty country without separate work authorization.

Medical practice financial projections must reflect the actual mechanics of healthcare billing. Revenue does not materialize on the day a patient is seen; claims are submitted to insurance payers, adjudicated, and reimbursed on a cycle that commonly runs 30 to 90 days from the date of service. The cash flow projections must model this lag explicitly — showing a receivables build-up in the first two to four months before cash collections begin to match claim volume. An officer or RFE reviewer who sees a projection in which revenue appears in month one of operations will lose confidence in the plan's credibility.

The revenue model should be built on CPT (Current Procedural Terminology) code-based assumptions, even if presented at a high level of abstraction. For example: 'The practice will see an estimated 20 patients per day in month three, growing to 35 per day by month six. The average reimbursement per encounter, blended across Medicare, Medicaid, and commercial payers, is approximately $[X] net of contractual adjustments. Monthly gross collections are therefore projected at $[Y] in month three.' This methodology grounds the projections in industry mechanics rather than aspirational round numbers.

The plan should also project operating expenses with the same specificity: malpractice insurance (which varies significantly by specialty — primary care premiums are far lower than surgical or OB/GYN premiums), staff salaries, rent, medical supplies, EHR subscription and billing service fees, and professional services. A five-year income statement and cash flow projection is standard; a break-even analysis identifying the patient volume or monthly revenue at which expenses are covered demonstrates that the investor has modeled the business rigorously.

One of the operational realities that E-2 business plans for medical practices frequently understate is the time between lease signing and first patient encounter. State medical licensing (if the investor-physician is relocating and has not yet obtained a state license) takes three to six months. DEA registration for controlled-substance prescribers can add another one to two months. Payer credentialing — enrollment with Medicare, Medicaid, and each contracted commercial insurer — routinely takes 90 to 180 days and cannot be rushed materially. An office may be built out and equipped and still have no revenue-generating capacity while credentialing is pending.

The business plan should acknowledge this pre-revenue period explicitly. The startup costs table should include the working capital reserve necessary to cover fixed costs (rent, insurance, staff salaries for any pre-hired employees) during the credentialing gap. The cash flow projection should show $0 in collections for the first two to three months if the practice is a de novo start-up, with revenue beginning only after the first payers complete enrollment. An honest treatment of this timeline demonstrates operational realism and reduces the likelihood of an RFE asking why the financial projections do not account for the credentialing period.

Several errors recur across rejected or RFE'd medical practice E-2 applications. The first is conflating the physician role with the investor role: plans that describe the investor primarily as a treating physician, with business management as an afterthought, invite a develop-and-direct finding against the applicant. The plan must lead with the investor's executive function and treat clinical activity as one element of that role.

The second is projecting revenue without explaining payer mix and reimbursement rates. Round-number projections — '$2 million in revenue by year three' without any explanation of how that figure was derived — give an officer nothing to evaluate and signal that the investor has not done the operational modeling. Third, failing to address the CPOM structure in a CPOM state is a preventable error that can result in denial on bona fide enterprise grounds even when the investment is genuine.

Fourth, and perhaps most common, is a staffing plan that shows no employees beyond the investor and a single assistant in year one, followed by an unexplained jump to a large workforce in year three. The staffing ramp must be tied to projected patient volume and revenue with a logical progression. Finally, plans that omit the credentialing and licensing timeline from the financial projections create an internal inconsistency between the operational narrative (which acknowledges the credentialing period) and the financial statements (which project revenue from month one). Officers notice these inconsistencies and they generate RFEs.